{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:47:42Z","timestamp":1776872862549,"version":"3.51.2"},"reference-count":49,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Systemic autoimmune rheumatic diseases (SARD) are associated with an increased risk of premature cardiovascular disease (CVD) and all-cause mortality. We examined the potential survival benefit of statin use among patients with SARD in a general population setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted an incident user cohort study using a UK general population database. Our population included patients with a SARD as determined by Read code diagnoses of systemic lupus erythematosus, systemic sclerosis, Sj\u00f6gren syndrome, dermatomyositis, polymyositis, mixed connective tissue disease, Beh\u00e7et disease, or antineutrophil cytoplasmic antibodies-associated vasculitis between January 1, 2000, and December 31, 2014. We compared propensity score\u2013matched cohorts of statin initiators and noninitiators within 1-year cohort accrual blocks to account for potential confounders, including disease duration, body mass index, lifestyle factors, comorbidities, and medication use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Of 2305 statin initiators, 298 died during the followup period (mean 5.1 yrs), whereas among 2305 propensity score\u2013matched noninitiators, 338 died during the followup period (mean 4.8 yrs). This corresponded to mortality rates of 25.4\/1000 and 30.3\/1000 person-years, respectively. Statin initiation was associated with reduced all-cause mortality (HR 0.84, 95% CI 0.72\u20130.98). When we compared the unmatched cohorts, the statin initiators (n = 2863) showed increased mortality (HR 1.85, 95% CI 1.58\u20132.16) compared with noninitiators (n = 2863 randomly selected within 1-year cohort accrual blocks) because of confounding by indication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In this general population\u2013based study, statin initiation was shown to reduce overall mortality in patients with SARD after adjusting for relevant determinates of CVD risk.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.171389","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T11:25:18Z","timestamp":1535801118000},"page":"1689-1695","source":"Crossref","is-referenced-by-count":27,"title":["The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases"],"prefix":"10.3899","volume":"45","author":[{"given":"April M.","family":"Jorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah F.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharan K.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyon K.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"2025021012250879000_45.12.1689.1","first-page":"168","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2025021012250879000_45.12.1689.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101149"},{"key":"2025021012250879000_45.12.1689.3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/03009742.2017.1337924","article-title":"Simple screening tools predict death and cardiovascular events in patients with rheumatic disease","volume":"47","author":"Breunig","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2025021012250879000_45.12.1689.4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","article-title":"Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases","volume":"15","author":"Bartoloni","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2025021012250879000_45.12.1689.5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20322"},{"key":"2025021012250879000_45.12.1689.6","doi-asserted-by":"crossref","first-page":"20303","DOI":"10.1038\/srep20303","article-title":"The prevalence of atherosclerosis in those with inflammatory connective tissue disease by race, age, and traditional risk factors","volume":"6","author":"Alenghat","year":"2016","journal-title":"Sci Rep"},{"key":"2025021012250879000_45.12.1689.7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avi\u00f1a-Zubieta","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2025021012250879000_45.12.1689.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.12.002"},{"key":"2025021012250879000_45.12.1689.9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90431-9"},{"key":"2025021012250879000_45.12.1689.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130874"},{"key":"2025021012250879000_45.12.1689.11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study","volume":"61","author":"Hak","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250879000_45.12.1689.12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315627202"},{"key":"2025021012250879000_45.12.1689.13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/rheumatology\/kex412","article-title":"Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999\u20132014)","volume":"57","author":"Jorge","year":"2018","journal-title":"Rheumatology"},{"key":"2025021012250879000_45.12.1689.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202007"},{"key":"2025021012250879000_45.12.1689.15","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/art.39762","article-title":"Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (Wegener\u2019s): a population-based study","volume":"68","author":"Avi\u00f1a-Zubieta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250879000_45.12.1689.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210942"},{"key":"2025021012250879000_45.12.1689.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev336"},{"key":"2025021012250879000_45.12.1689.18","doi-asserted-by":"publisher","DOI":"10.1186\/ar4135"},{"key":"2025021012250879000_45.12.1689.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211402"},{"key":"2025021012250879000_45.12.1689.20","doi-asserted-by":"crossref","unstructured":"Taylor F Huffman MD Macedo AF Moore TH Burke M Davey Smith G Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013:CD004816.","DOI":"10.1002\/14651858.CD004816.pub5"},{"key":"2025021012250879000_45.12.1689.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"2025021012250879000_45.12.1689.22","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"2025021012250879000_45.12.1689.23","unstructured":"NHS Digital. Read Codes. [Internet. Accessed June 11, 2018.] Available from: digital.nhs.uk\/article\/1104\/Read-Codes"},{"key":"2025021012250879000_45.12.1689.24","unstructured":"FDB . Multilex. [Internet. Accessed June 11, 2018.] Available from: www.fdbhealth.co.uk\/solutions\/multilex"},{"key":"2025021012250879000_45.12.1689.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160327"},{"key":"2025021012250879000_45.12.1689.26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","article-title":"Giant cell arteritis and polymyalgia rheumatica: an update","volume":"17","author":"Gonzalez-Gay","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2025021012250879000_45.12.1689.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"2025021012250879000_45.12.1689.28","doi-asserted-by":"publisher","DOI":"10.2307\/2669455"},{"key":"2025021012250879000_45.12.1689.29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6004"},{"key":"2025021012250879000_45.12.1689.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.057"},{"key":"2025021012250879000_45.12.1689.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2008-6"},{"key":"2025021012250879000_45.12.1689.32","doi-asserted-by":"publisher","DOI":"10.1038\/nri1839"},{"key":"2025021012250879000_45.12.1689.33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.autrev.2015.12.007","article-title":"Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: a systematic review and meta-analysis of controlled trials","volume":"15","author":"Sahebkar","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2025021012250879000_45.12.1689.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.03.018"},{"key":"2025021012250879000_45.12.1689.35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.bor.0000245720.02512.3e","article-title":"Potential benefit of statins for vascular disease in systemic sclerosis","volume":"18","author":"Kuwana","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2025021012250879000_45.12.1689.36","first-page":"477","article-title":"Simvastatin inhibits neutrophil degranulation induced by anti-neutrophil cytoplasm auto-antibodies and N-formylmethionine-leucine-phenylalanine (fMLP) peptide","volume":"34","author":"Al-Ani","year":"2013","journal-title":"Saudi Med J"},{"key":"2025021012250879000_45.12.1689.37","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250879000_45.12.1689.38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rdc.2015.08.010","article-title":"Corticosteroids in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"42","author":"Keller","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"2025021012250879000_45.12.1689.39","first-page":"i114","article-title":"It hasn\u2019t gone away: the problem of glucocorticoid use in lupus remains","volume":"56","author":"Apostolopoulos","year":"2017","journal-title":"Rheumatology"},{"key":"2025021012250879000_45.12.1689.40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.autrev.2017.05.001","article-title":"Physical inactivity and sedentary behavior: Overlooked risk factors in autoimmune rheumatic diseases?","volume":"16","author":"Pinto","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2025021012250879000_45.12.1689.41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.14423\/SMJ.0000000000000561","article-title":"Effects of statin therapy in patients with systemic lupus erythematosus","volume":"109","author":"Artola","year":"2016","journal-title":"South Med J"},{"key":"2025021012250879000_45.12.1689.42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1177\/0961203317704710","article-title":"Management of cardiovascular risk in systemic lupus erythematosus: a systematic review","volume":"26","author":"Andrades","year":"2017","journal-title":"Lupus"},{"key":"2025021012250879000_45.12.1689.43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136762"},{"key":"2025021012250879000_45.12.1689.44","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20440"},{"key":"2025021012250879000_45.12.1689.45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.30645","article-title":"Use of atorvastatin in systemic lupus erythematosus in children and adolescents","volume":"64","author":"Schanberg","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250879000_45.12.1689.46","doi-asserted-by":"publisher","DOI":"10.1186\/ar3402"},{"key":"2025021012250879000_45.12.1689.47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2015.08.030","article-title":"Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study","volume":"243","author":"Yu","year":"2015","journal-title":"Atherosclerosis"},{"key":"2025021012250879000_45.12.1689.48","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"2025021012250879000_45.12.1689.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5087"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.171389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:26:35Z","timestamp":1739219195000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.171389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.3899\/jrheum.171389"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.171389","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}